ALDH18A1 and metabolic dysfunction-associated steatotic liver disease: We aimed to evaluate the diagnostic performance of GPR for liver fibrosis in patients with chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD).